Changchun BCHT Biotechnology Co. (SHA:688276)

Market Cap	8.82B
Revenue (ttm)	1.23B
Net Income (ttm)	232.09M
Shares Out	413.66M
EPS (ttm)	0.56
PE Ratio	21.32
Forward PE	14.64
Dividend	0.15 (0.70%)
Ex-Dividend Date	May 24, 2024

Volume	3,654,242
Average Volume	2,137,240
Open	21.29
Previous Close	21.32
Day's Range	21.21 - 21.77
52-Week Range	20.19 - 36.05
Beta	0.01
RSI	51.86
Earnings Date	Aug 15, 2025

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 1,241
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688276

Financial Performance

In 2024, SHA:688276's revenue was 1.23 billion, a decrease of -32.64% compared to the previous year's 1.82 billion. Earnings were 232.09 million, a decrease of -53.67%.